nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—hematopoietic system—hematologic cancer	0.0105	0.134	CbGeAlD
Acamprosate—GRIN3B—lung—hematologic cancer	0.0097	0.123	CbGeAlD
Acamprosate—GRIN3B—testis—hematologic cancer	0.00915	0.116	CbGeAlD
Acamprosate—GRM5—blood—hematologic cancer	0.00698	0.0887	CbGeAlD
Acamprosate—GRM5—testis—hematologic cancer	0.00577	0.0733	CbGeAlD
Acamprosate—GRIN2C—testis—hematologic cancer	0.0044	0.0559	CbGeAlD
Acamprosate—SLC36A1—gonad—hematologic cancer	0.00419	0.0532	CbGeAlD
Acamprosate—GRIN2D—testis—hematologic cancer	0.00409	0.0519	CbGeAlD
Acamprosate—GRIN3A—testis—hematologic cancer	0.00384	0.0488	CbGeAlD
Acamprosate—SLC36A1—bone marrow—hematologic cancer	0.00353	0.0449	CbGeAlD
Acamprosate—SLC36A1—lung—hematologic cancer	0.0032	0.0407	CbGeAlD
Acamprosate—GRIN2A—testis—hematologic cancer	0.00304	0.0386	CbGeAlD
Acamprosate—SLC36A1—testis—hematologic cancer	0.00302	0.0384	CbGeAlD
Acamprosate—SLC36A1—lymph node—hematologic cancer	0.00219	0.0278	CbGeAlD
Acamprosate—GABRB3—gonad—hematologic cancer	0.00204	0.0259	CbGeAlD
Acamprosate—GABRB3—lung—hematologic cancer	0.00156	0.0198	CbGeAlD
Acamprosate—GABRB3—testis—hematologic cancer	0.00147	0.0187	CbGeAlD
Acamprosate—GABRG2—Transmembrane transport of small molecules—NUP98—hematologic cancer	6.53e-05	0.000252	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—CREB1—hematologic cancer	6.53e-05	0.000252	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RASGRP1—hematologic cancer	6.53e-05	0.000252	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HSP90AA1—hematologic cancer	6.51e-05	0.000251	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SYK—hematologic cancer	6.51e-05	0.000251	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—hematologic cancer	6.5e-05	0.000251	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—JAK1—hematologic cancer	6.48e-05	0.00025	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ADCY7—hematologic cancer	6.46e-05	0.000249	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CD—hematologic cancer	6.45e-05	0.000249	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FOXO1—hematologic cancer	6.45e-05	0.000249	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—BRAF—hematologic cancer	6.45e-05	0.000249	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—CREB1—hematologic cancer	6.41e-05	0.000248	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—NUP214—hematologic cancer	6.41e-05	0.000248	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6R—hematologic cancer	6.4e-05	0.000247	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CREB1—hematologic cancer	6.35e-05	0.000245	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	6.34e-05	0.000245	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—BRAF—hematologic cancer	6.33e-05	0.000245	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—JAK1—hematologic cancer	6.32e-05	0.000244	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—NUP214—hematologic cancer	6.3e-05	0.000243	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—hematologic cancer	6.29e-05	0.000243	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCG2—hematologic cancer	6.28e-05	0.000243	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MDM2—hematologic cancer	6.27e-05	0.000242	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT1—hematologic cancer	6.27e-05	0.000242	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—HRAS—hematologic cancer	6.27e-05	0.000242	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAP2K1—hematologic cancer	6.26e-05	0.000242	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL2—hematologic cancer	6.21e-05	0.00024	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6R—hematologic cancer	6.19e-05	0.000239	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	6.17e-05	0.000238	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—hematologic cancer	6.17e-05	0.000238	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MDM2—hematologic cancer	6.12e-05	0.000236	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—JUN—hematologic cancer	6.11e-05	0.000236	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAP2K1—hematologic cancer	6.1e-05	0.000236	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3R1—hematologic cancer	6.09e-05	0.000235	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	6.05e-05	0.000234	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	5.98e-05	0.000231	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—JAK2—hematologic cancer	5.92e-05	0.000229	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAP2K1—hematologic cancer	5.9e-05	0.000228	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GRB2—hematologic cancer	5.87e-05	0.000227	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CD—hematologic cancer	5.86e-05	0.000226	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFA—hematologic cancer	5.86e-05	0.000226	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—hematologic cancer	5.84e-05	0.000226	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	5.83e-05	0.000225	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCG—hematologic cancer	5.8e-05	0.000224	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—hematologic cancer	5.78e-05	0.000223	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KITLG—hematologic cancer	5.77e-05	0.000223	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.71e-05	0.000221	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—JAK2—hematologic cancer	5.7e-05	0.00022	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—hematologic cancer	5.7e-05	0.00022	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT5A—hematologic cancer	5.64e-05	0.000218	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CB—hematologic cancer	5.63e-05	0.000217	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—CREB1—hematologic cancer	5.6e-05	0.000217	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.6e-05	0.000216	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN2B—hematologic cancer	5.59e-05	0.000216	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—JAK2—hematologic cancer	5.56e-05	0.000215	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.54e-05	0.000214	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BRAF—hematologic cancer	5.53e-05	0.000214	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3R1—hematologic cancer	5.53e-05	0.000214	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.5e-05	0.000213	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.5e-05	0.000212	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—SRC—hematologic cancer	5.48e-05	0.000212	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK14—hematologic cancer	5.44e-05	0.00021	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD86—hematologic cancer	5.41e-05	0.000209	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MDM2—hematologic cancer	5.4e-05	0.000209	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.39e-05	0.000208	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—JAK2—hematologic cancer	5.38e-05	0.000208	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MET—hematologic cancer	5.36e-05	0.000207	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CDK4—hematologic cancer	5.36e-05	0.000207	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HES1—hematologic cancer	5.33e-05	0.000206	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MDM2—hematologic cancer	5.3e-05	0.000205	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NCOR1—hematologic cancer	5.3e-05	0.000205	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK14—hematologic cancer	5.3e-05	0.000205	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—hematologic cancer	5.28e-05	0.000204	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—hematologic cancer	5.25e-05	0.000203	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CSF2—hematologic cancer	5.24e-05	0.000203	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF1—hematologic cancer	5.24e-05	0.000203	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CDK4—hematologic cancer	5.22e-05	0.000202	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MET—hematologic cancer	5.22e-05	0.000202	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—HRAS—hematologic cancer	5.17e-05	0.0002	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FOXO1—hematologic cancer	5.17e-05	0.0002	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—hematologic cancer	5.17e-05	0.0002	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—hematologic cancer	5.16e-05	0.000199	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFRB—hematologic cancer	5.16e-05	0.000199	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NOTCH1—hematologic cancer	5.16e-05	0.000199	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.15e-05	0.000199	CbGpPWpGaD
Acamprosate—Skin disorder—Prednisone—hematologic cancer	5.11e-05	7.71e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PIK3CB—hematologic cancer	5.11e-05	0.000197	CbGpPWpGaD
Acamprosate—Nausea—Gemcitabine—hematologic cancer	5.11e-05	7.71e-05	CcSEcCtD
Acamprosate—Vomiting—Cisplatin—hematologic cancer	5.1e-05	7.69e-05	CcSEcCtD
Acamprosate—Hyperhidrosis—Prednisone—hematologic cancer	5.09e-05	7.68e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PDGFRA—hematologic cancer	5.08e-05	0.000196	CbGpPWpGaD
Acamprosate—Mental disorder—Epirubicin—hematologic cancer	5.07e-05	7.66e-05	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	5.07e-05	0.000196	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	5.06e-05	0.000196	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JAK1—hematologic cancer	5.06e-05	0.000196	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCG—hematologic cancer	5.06e-05	0.000196	CbGpPWpGaD
Acamprosate—Rash—Cisplatin—hematologic cancer	5.05e-05	7.63e-05	CcSEcCtD
Acamprosate—Dermatitis—Cisplatin—hematologic cancer	5.05e-05	7.62e-05	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK3—hematologic cancer	5.05e-05	0.000195	CbGpPWpGaD
Acamprosate—Malnutrition—Epirubicin—hematologic cancer	5.04e-05	7.61e-05	CcSEcCtD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—hematologic cancer	5.03e-05	0.000194	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NOTCH1—hematologic cancer	5.03e-05	0.000194	CbGpPWpGaD
Acamprosate—Diarrhoea—Etoposide—hematologic cancer	5.02e-05	7.58e-05	CcSEcCtD
Acamprosate—Anorexia—Prednisone—hematologic cancer	5.02e-05	7.57e-05	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—CREB1—hematologic cancer	5e-05	0.000193	CbGpPWpGaD
Acamprosate—Ill-defined disorder—Methotrexate—hematologic cancer	5e-05	7.55e-05	CcSEcCtD
Acamprosate—Tinnitus—Doxorubicin—hematologic cancer	5e-05	7.54e-05	CcSEcCtD
Acamprosate—Anaemia—Methotrexate—hematologic cancer	4.98e-05	7.52e-05	CcSEcCtD
Acamprosate—Feeling abnormal—Dexamethasone—hematologic cancer	4.98e-05	7.52e-05	CcSEcCtD
Acamprosate—Feeling abnormal—Betamethasone—hematologic cancer	4.98e-05	7.52e-05	CcSEcCtD
Acamprosate—Flatulence—Epirubicin—hematologic cancer	4.97e-05	7.5e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—PTPN11—hematologic cancer	4.96e-05	0.000191	CbGpPWpGaD
Acamprosate—Tension—Epirubicin—hematologic cancer	4.95e-05	7.47e-05	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.94e-05	7.46e-05	CcSEcCtD
Acamprosate—Gastrointestinal pain—Betamethasone—hematologic cancer	4.94e-05	7.46e-05	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—BRAF—hematologic cancer	4.94e-05	0.000191	CbGpPWpGaD
Acamprosate—Dysgeusia—Epirubicin—hematologic cancer	4.94e-05	7.45e-05	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—JUN—hematologic cancer	4.92e-05	0.00019	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—CREB1—hematologic cancer	4.91e-05	0.00019	CbGpPWpGaD
Acamprosate—Hypersensitivity—Triamcinolone—hematologic cancer	4.91e-05	7.41e-05	CcSEcCtD
Acamprosate—Nervousness—Epirubicin—hematologic cancer	4.9e-05	7.39e-05	CcSEcCtD
Acamprosate—Back pain—Epirubicin—hematologic cancer	4.88e-05	7.36e-05	CcSEcCtD
Acamprosate—Malaise—Methotrexate—hematologic cancer	4.86e-05	7.33e-05	CcSEcCtD
Acamprosate—Dizziness—Etoposide—hematologic cancer	4.85e-05	7.33e-05	CcSEcCtD
Acamprosate—GABRG2—Neuronal System—BRAF—hematologic cancer	4.85e-05	0.000187	CbGpPWpGaD
Acamprosate—Muscle spasms—Epirubicin—hematologic cancer	4.85e-05	7.32e-05	CcSEcCtD
Acamprosate—Immune system disorder—Doxorubicin—hematologic cancer	4.84e-05	7.31e-05	CcSEcCtD
Acamprosate—Vertigo—Methotrexate—hematologic cancer	4.84e-05	7.31e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—PTPN11—hematologic cancer	4.83e-05	0.000187	CbGpPWpGaD
Acamprosate—Leukopenia—Methotrexate—hematologic cancer	4.82e-05	7.28e-05	CcSEcCtD
Acamprosate—Chills—Doxorubicin—hematologic cancer	4.81e-05	7.26e-05	CcSEcCtD
Acamprosate—GRIN2D—Neuronal System—HRAS—hematologic cancer	4.81e-05	0.000186	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.81e-05	0.000186	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CREB1—hematologic cancer	4.8e-05	0.000185	CbGpPWpGaD
Acamprosate—Urticaria—Dexamethasone—hematologic cancer	4.8e-05	7.25e-05	CcSEcCtD
Acamprosate—Urticaria—Betamethasone—hematologic cancer	4.8e-05	7.25e-05	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.79e-05	7.24e-05	CcSEcCtD
Acamprosate—Dizziness—Prednisolone—hematologic cancer	4.79e-05	7.23e-05	CcSEcCtD
Acamprosate—Asthenia—Triamcinolone—hematologic cancer	4.78e-05	7.21e-05	CcSEcCtD
Acamprosate—Abdominal pain—Dexamethasone—hematologic cancer	4.78e-05	7.21e-05	CcSEcCtD
Acamprosate—Abdominal pain—Betamethasone—hematologic cancer	4.78e-05	7.21e-05	CcSEcCtD
Acamprosate—Body temperature increased—Dexamethasone—hematologic cancer	4.78e-05	7.21e-05	CcSEcCtD
Acamprosate—Body temperature increased—Betamethasone—hematologic cancer	4.78e-05	7.21e-05	CcSEcCtD
Acamprosate—Nausea—Cisplatin—hematologic cancer	4.76e-05	7.19e-05	CcSEcCtD
Acamprosate—Insomnia—Prednisone—hematologic cancer	4.76e-05	7.18e-05	CcSEcCtD
Acamprosate—Alopecia—Doxorubicin—hematologic cancer	4.74e-05	7.15e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—IL2RA—hematologic cancer	4.73e-05	0.000183	CbGpPWpGaD
Acamprosate—Paraesthesia—Prednisone—hematologic cancer	4.72e-05	7.13e-05	CcSEcCtD
Acamprosate—Pruritus—Triamcinolone—hematologic cancer	4.71e-05	7.11e-05	CcSEcCtD
Acamprosate—Cough—Methotrexate—hematologic cancer	4.7e-05	7.1e-05	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.7e-05	0.000182	CbGpPWpGaD
Acamprosate—Mental disorder—Doxorubicin—hematologic cancer	4.7e-05	7.09e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—IL2—hematologic cancer	4.69e-05	0.000181	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6R—hematologic cancer	4.68e-05	0.000181	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CREB1—hematologic cancer	4.68e-05	0.000181	CbGpPWpGaD
Acamprosate—Ill-defined disorder—Epirubicin—hematologic cancer	4.68e-05	7.06e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—CREBBP—hematologic cancer	4.68e-05	0.000181	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TERT—hematologic cancer	4.67e-05	0.000181	CbGpPWpGaD
Acamprosate—Convulsion—Methotrexate—hematologic cancer	4.67e-05	7.05e-05	CcSEcCtD
Acamprosate—Vomiting—Etoposide—hematologic cancer	4.67e-05	7.05e-05	CcSEcCtD
Acamprosate—Malnutrition—Doxorubicin—hematologic cancer	4.67e-05	7.04e-05	CcSEcCtD
Acamprosate—Anaemia—Epirubicin—hematologic cancer	4.66e-05	7.03e-05	CcSEcCtD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MDM2—hematologic cancer	4.64e-05	0.000179	CbGpPWpGaD
Acamprosate—Agitation—Epirubicin—hematologic cancer	4.63e-05	6.99e-05	CcSEcCtD
Acamprosate—Dyspepsia—Prednisone—hematologic cancer	4.63e-05	6.99e-05	CcSEcCtD
Acamprosate—Rash—Etoposide—hematologic cancer	4.63e-05	6.99e-05	CcSEcCtD
Acamprosate—Dermatitis—Etoposide—hematologic cancer	4.62e-05	6.98e-05	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.61e-05	0.000178	CbGpPWpGaD
Acamprosate—Headache—Etoposide—hematologic cancer	4.6e-05	6.94e-05	CcSEcCtD
Acamprosate—Flatulence—Doxorubicin—hematologic cancer	4.6e-05	6.94e-05	CcSEcCtD
Acamprosate—Myalgia—Methotrexate—hematologic cancer	4.59e-05	6.92e-05	CcSEcCtD
Acamprosate—Chest pain—Methotrexate—hematologic cancer	4.59e-05	6.92e-05	CcSEcCtD
Acamprosate—Arthralgia—Methotrexate—hematologic cancer	4.59e-05	6.92e-05	CcSEcCtD
Acamprosate—Tension—Doxorubicin—hematologic cancer	4.58e-05	6.91e-05	CcSEcCtD
Acamprosate—Decreased appetite—Prednisone—hematologic cancer	4.57e-05	6.9e-05	CcSEcCtD
Acamprosate—Dysgeusia—Doxorubicin—hematologic cancer	4.57e-05	6.9e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—IL6R—hematologic cancer	4.57e-05	0.000176	CbGpPWpGaD
Acamprosate—Rash—Prednisolone—hematologic cancer	4.57e-05	6.89e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PDGFB—hematologic cancer	4.56e-05	0.000176	CbGpPWpGaD
Acamprosate—Dermatitis—Prednisolone—hematologic cancer	4.56e-05	6.89e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—CREBBP—hematologic cancer	4.56e-05	0.000176	CbGpPWpGaD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.56e-05	6.88e-05	CcSEcCtD
Acamprosate—Malaise—Epirubicin—hematologic cancer	4.55e-05	6.86e-05	CcSEcCtD
Acamprosate—Headache—Prednisolone—hematologic cancer	4.54e-05	6.85e-05	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—EP300—hematologic cancer	4.54e-05	0.000175	CbGpPWpGaD
Acamprosate—Discomfort—Methotrexate—hematologic cancer	4.53e-05	6.84e-05	CcSEcCtD
Acamprosate—Nervousness—Doxorubicin—hematologic cancer	4.53e-05	6.84e-05	CcSEcCtD
Acamprosate—Vertigo—Epirubicin—hematologic cancer	4.53e-05	6.84e-05	CcSEcCtD
Acamprosate—Syncope—Epirubicin—hematologic cancer	4.52e-05	6.83e-05	CcSEcCtD
Acamprosate—Leukopenia—Epirubicin—hematologic cancer	4.51e-05	6.81e-05	CcSEcCtD
Acamprosate—Back pain—Doxorubicin—hematologic cancer	4.51e-05	6.81e-05	CcSEcCtD
Acamprosate—Constipation—Prednisone—hematologic cancer	4.5e-05	6.79e-05	CcSEcCtD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.49e-05	0.000174	CbGpPWpGaD
Acamprosate—Muscle spasms—Doxorubicin—hematologic cancer	4.49e-05	6.77e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—MAP2K1—hematologic cancer	4.46e-05	0.000172	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TSC2—hematologic cancer	4.46e-05	0.000172	CbGpPWpGaD
Acamprosate—Palpitations—Epirubicin—hematologic cancer	4.46e-05	6.73e-05	CcSEcCtD
Acamprosate—Confusional state—Methotrexate—hematologic cancer	4.43e-05	6.69e-05	CcSEcCtD
Acamprosate—Loss of consciousness—Epirubicin—hematologic cancer	4.43e-05	6.69e-05	CcSEcCtD
Acamprosate—Dizziness—Triamcinolone—hematologic cancer	4.4e-05	6.65e-05	CcSEcCtD
Acamprosate—Cough—Epirubicin—hematologic cancer	4.4e-05	6.64e-05	CcSEcCtD
Acamprosate—Anaphylactic shock—Methotrexate—hematologic cancer	4.4e-05	6.64e-05	CcSEcCtD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—hematologic cancer	4.38e-05	0.000169	CbGpPWpGaD
Acamprosate—Convulsion—Epirubicin—hematologic cancer	4.37e-05	6.59e-05	CcSEcCtD
Acamprosate—Infection—Methotrexate—hematologic cancer	4.37e-05	6.59e-05	CcSEcCtD
Acamprosate—Nausea—Etoposide—hematologic cancer	4.36e-05	6.58e-05	CcSEcCtD
Acamprosate—Hypertension—Epirubicin—hematologic cancer	4.35e-05	6.57e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—MAP2K1—hematologic cancer	4.35e-05	0.000168	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—SRC—hematologic cancer	4.34e-05	0.000168	CbGpPWpGaD
Acamprosate—Feeling abnormal—Prednisone—hematologic cancer	4.34e-05	6.55e-05	CcSEcCtD
Acamprosate—Asthenia—Betamethasone—hematologic cancer	4.33e-05	6.54e-05	CcSEcCtD
Acamprosate—Asthenia—Dexamethasone—hematologic cancer	4.33e-05	6.54e-05	CcSEcCtD
Acamprosate—Ill-defined disorder—Doxorubicin—hematologic cancer	4.33e-05	6.53e-05	CcSEcCtD
Acamprosate—Anaemia—Doxorubicin—hematologic cancer	4.31e-05	6.51e-05	CcSEcCtD
Acamprosate—Thrombocytopenia—Methotrexate—hematologic cancer	4.31e-05	6.5e-05	CcSEcCtD
Acamprosate—Gastrointestinal pain—Prednisone—hematologic cancer	4.3e-05	6.49e-05	CcSEcCtD
Acamprosate—Nausea—Prednisolone—hematologic cancer	4.3e-05	6.49e-05	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	4.3e-05	0.000166	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—CREB1—hematologic cancer	4.29e-05	0.000166	CbGpPWpGaD
Acamprosate—Myalgia—Epirubicin—hematologic cancer	4.29e-05	6.48e-05	CcSEcCtD
Acamprosate—Chest pain—Epirubicin—hematologic cancer	4.29e-05	6.48e-05	CcSEcCtD
Acamprosate—Arthralgia—Epirubicin—hematologic cancer	4.29e-05	6.48e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FGFR3—hematologic cancer	4.29e-05	0.000166	CbGpPWpGaD
Acamprosate—Agitation—Doxorubicin—hematologic cancer	4.29e-05	6.47e-05	CcSEcCtD
Acamprosate—Anxiety—Epirubicin—hematologic cancer	4.28e-05	6.46e-05	CcSEcCtD
Acamprosate—Pruritus—Betamethasone—hematologic cancer	4.27e-05	6.45e-05	CcSEcCtD
Acamprosate—Pruritus—Dexamethasone—hematologic cancer	4.27e-05	6.45e-05	CcSEcCtD
Acamprosate—Skin disorder—Methotrexate—hematologic cancer	4.27e-05	6.45e-05	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.26e-05	6.44e-05	CcSEcCtD
Acamprosate—Hyperhidrosis—Methotrexate—hematologic cancer	4.25e-05	6.42e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—MAPK14—hematologic cancer	4.25e-05	0.000164	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FGF2—hematologic cancer	4.25e-05	0.000164	CbGpPWpGaD
Acamprosate—Discomfort—Epirubicin—hematologic cancer	4.24e-05	6.4e-05	CcSEcCtD
Acamprosate—GABRA1—Neuronal System—BRAF—hematologic cancer	4.24e-05	0.000164	CbGpPWpGaD
Acamprosate—Vomiting—Triamcinolone—hematologic cancer	4.23e-05	6.39e-05	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—SRC—hematologic cancer	4.23e-05	0.000163	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—hematologic cancer	4.23e-05	0.000163	CbGpPWpGaD
Acamprosate—Malaise—Doxorubicin—hematologic cancer	4.21e-05	6.35e-05	CcSEcCtD
Acamprosate—Rash—Triamcinolone—hematologic cancer	4.2e-05	6.34e-05	CcSEcCtD
Acamprosate—Dry mouth—Epirubicin—hematologic cancer	4.2e-05	6.34e-05	CcSEcCtD
Acamprosate—Dermatitis—Triamcinolone—hematologic cancer	4.19e-05	6.33e-05	CcSEcCtD
Acamprosate—Vertigo—Doxorubicin—hematologic cancer	4.19e-05	6.33e-05	CcSEcCtD
Acamprosate—Anorexia—Methotrexate—hematologic cancer	4.19e-05	6.33e-05	CcSEcCtD
Acamprosate—Syncope—Doxorubicin—hematologic cancer	4.18e-05	6.32e-05	CcSEcCtD
Acamprosate—Urticaria—Prednisone—hematologic cancer	4.18e-05	6.31e-05	CcSEcCtD
Acamprosate—Leukopenia—Doxorubicin—hematologic cancer	4.18e-05	6.3e-05	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—NRAS—hematologic cancer	4.18e-05	0.000161	CbGpPWpGaD
Acamprosate—Headache—Triamcinolone—hematologic cancer	4.17e-05	6.3e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—ESR1—hematologic cancer	4.17e-05	0.000161	CbGpPWpGaD
Acamprosate—Body temperature increased—Prednisone—hematologic cancer	4.16e-05	6.28e-05	CcSEcCtD
Acamprosate—Abdominal pain—Prednisone—hematologic cancer	4.16e-05	6.28e-05	CcSEcCtD
Acamprosate—Confusional state—Epirubicin—hematologic cancer	4.15e-05	6.26e-05	CcSEcCtD
Acamprosate—GABRB3—Neuronal System—MDM2—hematologic cancer	4.14e-05	0.00016	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FGF2—hematologic cancer	4.14e-05	0.00016	CbGpPWpGaD
Acamprosate—Diarrhoea—Betamethasone—hematologic cancer	4.13e-05	6.24e-05	CcSEcCtD
Acamprosate—Diarrhoea—Dexamethasone—hematologic cancer	4.13e-05	6.24e-05	CcSEcCtD
Acamprosate—Palpitations—Doxorubicin—hematologic cancer	4.12e-05	6.22e-05	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—VEGFA—hematologic cancer	4.12e-05	0.000159	CbGpPWpGaD
Acamprosate—Anaphylactic shock—Epirubicin—hematologic cancer	4.12e-05	6.21e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FN1—hematologic cancer	4.12e-05	0.000159	CbGpPWpGaD
Acamprosate—Hypotension—Methotrexate—hematologic cancer	4.11e-05	6.2e-05	CcSEcCtD
Acamprosate—Loss of consciousness—Doxorubicin—hematologic cancer	4.1e-05	6.19e-05	CcSEcCtD
Acamprosate—Infection—Epirubicin—hematologic cancer	4.09e-05	6.17e-05	CcSEcCtD
Acamprosate—Cough—Doxorubicin—hematologic cancer	4.07e-05	6.15e-05	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—NRAS—hematologic cancer	4.07e-05	0.000157	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—JAK2—hematologic cancer	4.07e-05	0.000157	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NFKBIA—hematologic cancer	4.07e-05	0.000157	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BAD—hematologic cancer	4.07e-05	0.000157	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MDM2—hematologic cancer	4.06e-05	0.000157	CbGpPWpGaD
Acamprosate—Shock—Epirubicin—hematologic cancer	4.05e-05	6.11e-05	CcSEcCtD
Acamprosate—Convulsion—Doxorubicin—hematologic cancer	4.04e-05	6.1e-05	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.03e-05	0.000156	CbGpPWpGaD
Acamprosate—Thrombocytopenia—Epirubicin—hematologic cancer	4.03e-05	6.08e-05	CcSEcCtD
Acamprosate—Hypertension—Doxorubicin—hematologic cancer	4.03e-05	6.08e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—NOTCH1—hematologic cancer	4.03e-05	0.000156	CbGpPWpGaD
Acamprosate—Tachycardia—Epirubicin—hematologic cancer	4.02e-05	6.06e-05	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.01e-05	6.05e-05	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—MAPK3—hematologic cancer	4e-05	0.000154	CbGpPWpGaD
Acamprosate—Skin disorder—Epirubicin—hematologic cancer	4e-05	6.03e-05	CcSEcCtD
Acamprosate—Dizziness—Dexamethasone—hematologic cancer	4e-05	6.03e-05	CcSEcCtD
Acamprosate—Dizziness—Betamethasone—hematologic cancer	4e-05	6.03e-05	CcSEcCtD
Acamprosate—Hyperhidrosis—Epirubicin—hematologic cancer	3.98e-05	6.01e-05	CcSEcCtD
Acamprosate—Insomnia—Methotrexate—hematologic cancer	3.98e-05	6e-05	CcSEcCtD
Acamprosate—Arthralgia—Doxorubicin—hematologic cancer	3.97e-05	6e-05	CcSEcCtD
Acamprosate—Chest pain—Doxorubicin—hematologic cancer	3.97e-05	6e-05	CcSEcCtD
Acamprosate—Myalgia—Doxorubicin—hematologic cancer	3.97e-05	6e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—JAK2—hematologic cancer	3.97e-05	0.000153	CbGpPWpGaD
Acamprosate—Anxiety—Doxorubicin—hematologic cancer	3.96e-05	5.98e-05	CcSEcCtD
Acamprosate—Nausea—Triamcinolone—hematologic cancer	3.96e-05	5.97e-05	CcSEcCtD
Acamprosate—Paraesthesia—Methotrexate—hematologic cancer	3.95e-05	5.96e-05	CcSEcCtD
Acamprosate—GRIN2A—Neuronal System—HRAS—hematologic cancer	3.95e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD80—hematologic cancer	3.95e-05	0.000152	CbGpPWpGaD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.94e-05	5.95e-05	CcSEcCtD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.94e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KIT—hematologic cancer	3.94e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CG—hematologic cancer	3.94e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NRAS—hematologic cancer	3.94e-05	0.000152	CbGpPWpGaD
Acamprosate—Discomfort—Doxorubicin—hematologic cancer	3.92e-05	5.92e-05	CcSEcCtD
Acamprosate—Anorexia—Epirubicin—hematologic cancer	3.92e-05	5.92e-05	CcSEcCtD
Acamprosate—Dyspnoea—Methotrexate—hematologic cancer	3.92e-05	5.92e-05	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.92e-05	0.000151	CbGpPWpGaD
Acamprosate—Somnolence—Methotrexate—hematologic cancer	3.91e-05	5.9e-05	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—MAPK3—hematologic cancer	3.9e-05	0.000151	CbGpPWpGaD
Acamprosate—Dry mouth—Doxorubicin—hematologic cancer	3.88e-05	5.86e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Prednisone—hematologic cancer	3.88e-05	5.85e-05	CcSEcCtD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.87e-05	0.00015	CbGpPWpGaD
Acamprosate—Dyspepsia—Methotrexate—hematologic cancer	3.87e-05	5.84e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PTPN11—hematologic cancer	3.87e-05	0.000149	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—hematologic cancer	3.86e-05	0.000149	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.85e-05	0.000149	CbGpPWpGaD
Acamprosate—Hypotension—Epirubicin—hematologic cancer	3.85e-05	5.8e-05	CcSEcCtD
Acamprosate—Vomiting—Betamethasone—hematologic cancer	3.84e-05	5.8e-05	CcSEcCtD
Acamprosate—Vomiting—Dexamethasone—hematologic cancer	3.84e-05	5.8e-05	CcSEcCtD
Acamprosate—Confusional state—Doxorubicin—hematologic cancer	3.84e-05	5.8e-05	CcSEcCtD
Acamprosate—Decreased appetite—Methotrexate—hematologic cancer	3.82e-05	5.77e-05	CcSEcCtD
Acamprosate—Rash—Dexamethasone—hematologic cancer	3.81e-05	5.75e-05	CcSEcCtD
Acamprosate—Rash—Betamethasone—hematologic cancer	3.81e-05	5.75e-05	CcSEcCtD
Acamprosate—Anaphylactic shock—Doxorubicin—hematologic cancer	3.81e-05	5.75e-05	CcSEcCtD
Acamprosate—Dermatitis—Dexamethasone—hematologic cancer	3.81e-05	5.75e-05	CcSEcCtD
Acamprosate—Dermatitis—Betamethasone—hematologic cancer	3.81e-05	5.75e-05	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.8e-05	5.73e-05	CcSEcCtD
Acamprosate—Headache—Betamethasone—hematologic cancer	3.79e-05	5.71e-05	CcSEcCtD
Acamprosate—Headache—Dexamethasone—hematologic cancer	3.79e-05	5.71e-05	CcSEcCtD
Acamprosate—Infection—Doxorubicin—hematologic cancer	3.78e-05	5.71e-05	CcSEcCtD
Acamprosate—Asthenia—Prednisone—hematologic cancer	3.78e-05	5.7e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—MAPK3—hematologic cancer	3.77e-05	0.000146	CbGpPWpGaD
Acamprosate—Pain—Methotrexate—hematologic cancer	3.76e-05	5.68e-05	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.75e-05	5.66e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CREB1—hematologic cancer	3.75e-05	0.000145	CbGpPWpGaD
Acamprosate—Shock—Doxorubicin—hematologic cancer	3.75e-05	5.65e-05	CcSEcCtD
Acamprosate—Thrombocytopenia—Doxorubicin—hematologic cancer	3.73e-05	5.63e-05	CcSEcCtD
Acamprosate—Pruritus—Prednisone—hematologic cancer	3.72e-05	5.62e-05	CcSEcCtD
Acamprosate—Insomnia—Epirubicin—hematologic cancer	3.72e-05	5.62e-05	CcSEcCtD
Acamprosate—Tachycardia—Doxorubicin—hematologic cancer	3.72e-05	5.61e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—BRAF—hematologic cancer	3.7e-05	0.000143	CbGpPWpGaD
Acamprosate—Skin disorder—Doxorubicin—hematologic cancer	3.7e-05	5.58e-05	CcSEcCtD
Acamprosate—Paraesthesia—Epirubicin—hematologic cancer	3.7e-05	5.58e-05	CcSEcCtD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—hematologic cancer	3.68e-05	0.000142	CbGpPWpGaD
Acamprosate—Hyperhidrosis—Doxorubicin—hematologic cancer	3.68e-05	5.56e-05	CcSEcCtD
Acamprosate—Dyspnoea—Epirubicin—hematologic cancer	3.67e-05	5.54e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CCL2—hematologic cancer	3.67e-05	0.000142	CbGpPWpGaD
Acamprosate—Somnolence—Epirubicin—hematologic cancer	3.66e-05	5.52e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—IL6R—hematologic cancer	3.66e-05	0.000141	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CREBBP—hematologic cancer	3.65e-05	0.000141	CbGpPWpGaD
Acamprosate—Anorexia—Doxorubicin—hematologic cancer	3.63e-05	5.48e-05	CcSEcCtD
Acamprosate—Feeling abnormal—Methotrexate—hematologic cancer	3.62e-05	5.47e-05	CcSEcCtD
Acamprosate—Dyspepsia—Epirubicin—hematologic cancer	3.62e-05	5.47e-05	CcSEcCtD
Acamprosate—Diarrhoea—Prednisone—hematologic cancer	3.6e-05	5.43e-05	CcSEcCtD
Acamprosate—Gastrointestinal pain—Methotrexate—hematologic cancer	3.6e-05	5.43e-05	CcSEcCtD
Acamprosate—GRIN1—Axon guidance—KRAS—hematologic cancer	3.59e-05	0.000139	CbGpPWpGaD
Acamprosate—Nausea—Dexamethasone—hematologic cancer	3.59e-05	5.42e-05	CcSEcCtD
Acamprosate—Nausea—Betamethasone—hematologic cancer	3.59e-05	5.42e-05	CcSEcCtD
Acamprosate—Decreased appetite—Epirubicin—hematologic cancer	3.58e-05	5.4e-05	CcSEcCtD
Acamprosate—Hypotension—Doxorubicin—hematologic cancer	3.56e-05	5.37e-05	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.55e-05	5.36e-05	CcSEcCtD
Acamprosate—GABRA1—Neuronal System—MDM2—hematologic cancer	3.55e-05	0.000137	CbGpPWpGaD
Acamprosate—Pain—Epirubicin—hematologic cancer	3.52e-05	5.31e-05	CcSEcCtD
Acamprosate—Constipation—Epirubicin—hematologic cancer	3.52e-05	5.31e-05	CcSEcCtD
Acamprosate—GRIN2B—Axon guidance—KRAS—hematologic cancer	3.5e-05	0.000135	CbGpPWpGaD
Acamprosate—Urticaria—Methotrexate—hematologic cancer	3.49e-05	5.27e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—MAP2K1—hematologic cancer	3.49e-05	0.000135	CbGpPWpGaD
Acamprosate—Dizziness—Prednisone—hematologic cancer	3.48e-05	5.25e-05	CcSEcCtD
Acamprosate—Abdominal pain—Methotrexate—hematologic cancer	3.48e-05	5.25e-05	CcSEcCtD
Acamprosate—Body temperature increased—Methotrexate—hematologic cancer	3.48e-05	5.25e-05	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.47e-05	5.24e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PIK3CD—hematologic cancer	3.46e-05	0.000134	CbGpPWpGaD
Acamprosate—Insomnia—Doxorubicin—hematologic cancer	3.44e-05	5.2e-05	CcSEcCtD
Acamprosate—GRIN1—Neuronal System—HRAS—hematologic cancer	3.44e-05	0.000133	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—hematologic cancer	3.43e-05	0.000132	CbGpPWpGaD
Acamprosate—Paraesthesia—Doxorubicin—hematologic cancer	3.42e-05	5.16e-05	CcSEcCtD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—hematologic cancer	3.4e-05	0.000132	CbGpPWpGaD
Acamprosate—Dyspnoea—Doxorubicin—hematologic cancer	3.39e-05	5.12e-05	CcSEcCtD
Acamprosate—Feeling abnormal—Epirubicin—hematologic cancer	3.39e-05	5.12e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—KRAS—hematologic cancer	3.39e-05	0.000131	CbGpPWpGaD
Acamprosate—Somnolence—Doxorubicin—hematologic cancer	3.39e-05	5.11e-05	CcSEcCtD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	3.38e-05	0.000131	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Epirubicin—hematologic cancer	3.37e-05	5.08e-05	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.36e-05	0.00013	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HRAS—hematologic cancer	3.36e-05	0.00013	CbGpPWpGaD
Acamprosate—Dyspepsia—Doxorubicin—hematologic cancer	3.35e-05	5.06e-05	CcSEcCtD
Acamprosate—Vomiting—Prednisone—hematologic cancer	3.35e-05	5.05e-05	CcSEcCtD
Acamprosate—Rash—Prednisone—hematologic cancer	3.32e-05	5.01e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FGF2—hematologic cancer	3.31e-05	0.000128	CbGpPWpGaD
Acamprosate—Dermatitis—Prednisone—hematologic cancer	3.31e-05	5e-05	CcSEcCtD
Acamprosate—Decreased appetite—Doxorubicin—hematologic cancer	3.31e-05	5e-05	CcSEcCtD
Acamprosate—Headache—Prednisone—hematologic cancer	3.3e-05	4.98e-05	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.29e-05	4.96e-05	CcSEcCtD
Acamprosate—Urticaria—Epirubicin—hematologic cancer	3.27e-05	4.93e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PIK3R1—hematologic cancer	3.27e-05	0.000126	CbGpPWpGaD
Acamprosate—Pain—Doxorubicin—hematologic cancer	3.26e-05	4.92e-05	CcSEcCtD
Acamprosate—Constipation—Doxorubicin—hematologic cancer	3.26e-05	4.92e-05	CcSEcCtD
Acamprosate—Body temperature increased—Epirubicin—hematologic cancer	3.25e-05	4.91e-05	CcSEcCtD
Acamprosate—Abdominal pain—Epirubicin—hematologic cancer	3.25e-05	4.91e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Methotrexate—hematologic cancer	3.24e-05	4.89e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—EP300—hematologic cancer	3.19e-05	0.000123	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JAK2—hematologic cancer	3.18e-05	0.000123	CbGpPWpGaD
Acamprosate—Asthenia—Methotrexate—hematologic cancer	3.16e-05	4.76e-05	CcSEcCtD
Acamprosate—Feeling abnormal—Doxorubicin—hematologic cancer	3.14e-05	4.74e-05	CcSEcCtD
Acamprosate—Nausea—Prednisone—hematologic cancer	3.13e-05	4.72e-05	CcSEcCtD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—hematologic cancer	3.11e-05	0.00012	CbGpPWpGaD
Acamprosate—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.11e-05	4.7e-05	CcSEcCtD
Acamprosate—Pruritus—Methotrexate—hematologic cancer	3.11e-05	4.7e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—EP300—hematologic cancer	3.1e-05	0.00012	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MDM2—hematologic cancer	3.1e-05	0.00012	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SRC—hematologic cancer	3.1e-05	0.00012	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—hematologic cancer	3.05e-05	0.000118	CbGpPWpGaD
Acamprosate—Hypersensitivity—Epirubicin—hematologic cancer	3.03e-05	4.58e-05	CcSEcCtD
Acamprosate—Urticaria—Doxorubicin—hematologic cancer	3.02e-05	4.57e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—SRC—hematologic cancer	3.02e-05	0.000117	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MTOR—hematologic cancer	3.02e-05	0.000117	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CB—hematologic cancer	3.02e-05	0.000117	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—hematologic cancer	3.02e-05	0.000117	CbGpPWpGaD
Acamprosate—Abdominal pain—Doxorubicin—hematologic cancer	3.01e-05	4.54e-05	CcSEcCtD
Acamprosate—Body temperature increased—Doxorubicin—hematologic cancer	3.01e-05	4.54e-05	CcSEcCtD
Acamprosate—Diarrhoea—Methotrexate—hematologic cancer	3.01e-05	4.54e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—STAT3—hematologic cancer	2.99e-05	0.000115	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NRAS—hematologic cancer	2.98e-05	0.000115	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—hematologic cancer	2.98e-05	0.000115	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—hematologic cancer	2.97e-05	0.000115	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.96e-05	0.000115	CbGpPWpGaD
Acamprosate—Asthenia—Epirubicin—hematologic cancer	2.95e-05	4.46e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—hematologic cancer	2.94e-05	0.000114	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—hematologic cancer	2.92e-05	0.000113	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—hematologic cancer	2.91e-05	0.000112	CbGpPWpGaD
Acamprosate—Pruritus—Epirubicin—hematologic cancer	2.91e-05	4.39e-05	CcSEcCtD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.91e-05	0.000112	CbGpPWpGaD
Acamprosate—Dizziness—Methotrexate—hematologic cancer	2.91e-05	4.39e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—NRAS—hematologic cancer	2.9e-05	0.000112	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—hematologic cancer	2.88e-05	0.000111	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK3—hematologic cancer	2.85e-05	0.00011	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—hematologic cancer	2.85e-05	0.00011	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1B—hematologic cancer	2.83e-05	0.000109	CbGpPWpGaD
Acamprosate—Diarrhoea—Epirubicin—hematologic cancer	2.82e-05	4.25e-05	CcSEcCtD
Acamprosate—Hypersensitivity—Doxorubicin—hematologic cancer	2.81e-05	4.23e-05	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—hematologic cancer	2.8e-05	0.000108	CbGpPWpGaD
Acamprosate—Vomiting—Methotrexate—hematologic cancer	2.8e-05	4.22e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—MAPK3—hematologic cancer	2.78e-05	0.000107	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—hematologic cancer	2.78e-05	0.000107	CbGpPWpGaD
Acamprosate—Rash—Methotrexate—hematologic cancer	2.77e-05	4.19e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—IL2—hematologic cancer	2.77e-05	0.000107	CbGpPWpGaD
Acamprosate—Dermatitis—Methotrexate—hematologic cancer	2.77e-05	4.18e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—TGFB1—hematologic cancer	2.77e-05	0.000107	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—hematologic cancer	2.76e-05	0.000107	CbGpPWpGaD
Acamprosate—Headache—Methotrexate—hematologic cancer	2.75e-05	4.16e-05	CcSEcCtD
Acamprosate—Asthenia—Doxorubicin—hematologic cancer	2.73e-05	4.12e-05	CcSEcCtD
Acamprosate—Dizziness—Epirubicin—hematologic cancer	2.72e-05	4.11e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CCND1—hematologic cancer	2.7e-05	0.000104	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—hematologic cancer	2.7e-05	0.000104	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—JUN—hematologic cancer	2.7e-05	0.000104	CbGpPWpGaD
Acamprosate—Pruritus—Doxorubicin—hematologic cancer	2.69e-05	4.07e-05	CcSEcCtD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.62e-05	0.000101	CbGpPWpGaD
Acamprosate—Vomiting—Epirubicin—hematologic cancer	2.62e-05	3.95e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—CDKN1A—hematologic cancer	2.61e-05	0.000101	CbGpPWpGaD
Acamprosate—Nausea—Methotrexate—hematologic cancer	2.61e-05	3.94e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—PTEN—hematologic cancer	2.61e-05	0.000101	CbGpPWpGaD
Acamprosate—Diarrhoea—Doxorubicin—hematologic cancer	2.61e-05	3.93e-05	CcSEcCtD
Acamprosate—Rash—Epirubicin—hematologic cancer	2.59e-05	3.92e-05	CcSEcCtD
Acamprosate—Dermatitis—Epirubicin—hematologic cancer	2.59e-05	3.91e-05	CcSEcCtD
Acamprosate—GRIN1—Developmental Biology—TNF—hematologic cancer	2.59e-05	9.99e-05	CbGpPWpGaD
Acamprosate—Headache—Epirubicin—hematologic cancer	2.58e-05	3.89e-05	CcSEcCtD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.57e-05	9.94e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—hematologic cancer	2.56e-05	9.91e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—hematologic cancer	2.55e-05	9.85e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.54e-05	9.83e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—hematologic cancer	2.54e-05	9.83e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—hematologic cancer	2.52e-05	9.74e-05	CbGpPWpGaD
Acamprosate—Dizziness—Doxorubicin—hematologic cancer	2.52e-05	3.8e-05	CcSEcCtD
Acamprosate—GRIN2B—Developmental Biology—KRAS—hematologic cancer	2.5e-05	9.66e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EP300—hematologic cancer	2.49e-05	9.61e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—hematologic cancer	2.45e-05	9.47e-05	CbGpPWpGaD
Acamprosate—Nausea—Epirubicin—hematologic cancer	2.44e-05	3.69e-05	CcSEcCtD
Acamprosate—Vomiting—Doxorubicin—hematologic cancer	2.42e-05	3.65e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—SRC—hematologic cancer	2.42e-05	9.34e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.41e-05	9.3e-05	CbGpPWpGaD
Acamprosate—Rash—Doxorubicin—hematologic cancer	2.4e-05	3.62e-05	CcSEcCtD
Acamprosate—Dermatitis—Doxorubicin—hematologic cancer	2.4e-05	3.62e-05	CcSEcCtD
Acamprosate—Headache—Doxorubicin—hematologic cancer	2.39e-05	3.6e-05	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—VEGFA—hematologic cancer	2.36e-05	9.1e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—hematologic cancer	2.33e-05	9.01e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NRAS—hematologic cancer	2.33e-05	8.99e-05	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—hematologic cancer	2.27e-05	8.77e-05	CbGpPWpGaD
Acamprosate—Nausea—Doxorubicin—hematologic cancer	2.26e-05	3.41e-05	CcSEcCtD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.25e-05	8.69e-05	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—hematologic cancer	2.23e-05	8.62e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK3—hematologic cancer	2.23e-05	8.61e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—hematologic cancer	2.18e-05	8.42e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—hematologic cancer	2.17e-05	8.37e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—hematologic cancer	2.16e-05	8.35e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—hematologic cancer	2.13e-05	8.21e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.1e-05	8.13e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—hematologic cancer	2.09e-05	8.06e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—hematologic cancer	2.03e-05	7.86e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—hematologic cancer	2e-05	7.74e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—hematologic cancer	1.95e-05	7.53e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—hematologic cancer	1.92e-05	7.44e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—hematologic cancer	1.88e-05	7.25e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—hematologic cancer	1.84e-05	7.11e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—hematologic cancer	1.78e-05	6.88e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—hematologic cancer	1.7e-05	6.57e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—hematologic cancer	1.63e-05	6.29e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—hematologic cancer	1.5e-05	5.81e-05	CbGpPWpGaD
